Pancreatitis Trial, Recruiting NCT07074379 Sponsor: Changhai Hospital Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07074379
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 85 years old.
  • People who have been diagnosed with chronic pancreatitis (long-term inflammation of the pancreas) that does not cause pain.
  • People who have never previously had a procedure called ERCP (a procedure to examine the pancreas and bile ducts) or ESWL (a treatment that uses shockwaves to break up stones in the pancreas).

Who may not be able to join:

  • People who have complications from their pancreas condition — such as fluid-filled sacs (pseudocysts), narrowing of the bile ducts, or abnormal connections between the pancreas and other areas — that need a procedure or surgery to treat.
  • People whose pancreatitis is caused by their immune system attacking the pancreas (autoimmune pancreatitis).
  • People where there is a concern that cancer may be present.
  • People who have previously had surgery on their pancreas or certain types of stomach bypass surgery (such as a Billroth II procedure).
  • People whose illness is at a very advanced or end-stage.
  • People who are pregnant or breastfeeding.
  • People for whom ESWL or ERCP treatment would not be safe for medical reasons (confirm with trial site).
  • People who do not wish to give their formal agreement to take part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613901960921

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changhai Hospital
Registry
ClinicalTrials.gov
Start date
21 July 2025
Est. completion
1 August 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Acute Pancreatitis Incidence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov